Korean aesthetic exosome quality documentation showing lyophilised vial characterisation certificate and regulatory compliance documents

Korean Exosome Products: A Practitioner's Guide to Selection and Use

The aesthetic exosome market is growing rapidly and unevenly. Alongside genuinely well-characterised, rigorously manufactured Korean products with transparent documentation, the market contains preparations making compelling regenerative claims while providing minimal evidence of their actual content, source, or regulatory classification. For practitioners, the ability to evaluate exosome products on scientific and regulatory grounds is essential.

Clinical laboratory setting showing PDRN product manufacturing quality control with regulatory documentation and pharmaceutical testing equipment

Korean PDRN Products: A Practitioner's Guide to Selection and Use

South Korea is the world's leading producer of pharmaceutical-grade PDRN injectables. The Korean PDRN industry has been developing, manufacturing, and exporting these products for over two decades — a timeline that gives Korean manufacturers an accumulated clinical knowledge base and manufacturing expertise that no other country's PDRN industry can currently match. For UK and EU practitioners, this means the best available PDRN products are, almost without exception, Korean in origin.